Item 1.01 Entry into a Material Definitive Agreement

Series B Convertible Preferred Stock Purchase Agreements

On January 7, 2021, comScore, Inc. (the "Company") entered into separate Series B Convertible Preferred Stock Purchase Agreements (individually, a "Purchase Agreement" and collectively, the "Purchase Agreements") with each of Charter Communications Holding Company, LLC, a Delaware limited liability company ("Charter"), Qurate Retail, Inc., a Delaware corporation ("Qurate"), and Pine Investor, LLC, a Delaware limited liability company wholly owned by funds advised by Cerberus Capital Management, L.P. ("Pine" and together with Charter and Qurate, referred to herein collectively, as the "Purchasers" and individually, as a "Purchaser"), pursuant to which, among other things, at the closing of the transactions contemplated thereby (the "Closing"), and on the terms and subject to the conditions set forth therein, the Company will issue and sell (a) to Charter, 27,509,203 shares of Series B Convertible Preferred Stock, par value $0.001 per share, of the Company ("Series B Preferred Stock") in exchange for $68,000,000, (b) to Qurate, 27,509,203 shares of Series B Preferred Stock in exchange for $68,000,000 and (c) to Pine, 27,509,203 shares of Series B Preferred Stock in exchange for $68,000,000 (collectively, the "Aggregate Purchase Price"), which Aggregate Purchase Price is subject to further adjustment for dilution in accordance with the terms of the Purchase Agreements (collectively, the "Transactions"). The proceeds of the Transactions will be used to pay off certain outstanding indebtedness of the Company, including the outstanding indebtedness under the Company Notes (as defined below).

The board of directors of the Company (the "Board") has (a) determined that it is in the best interests of the Company and its stockholders (the "Company Stockholders") that the Company enter into the Purchase Agreements and the other Transaction Documents and consummate the Transactions and the other transactions contemplated thereby on the terms and subject to the conditions set forth therein, (b) approved and declared advisable the Purchase Agreements, the other Transaction Documents, the Transactions and the other transactions contemplated thereby on the terms and subject to the conditions set forth therein, (c) resolved to recommend that the Company Stockholders approve the Transactions and adopt the Certificate of Amendment (as defined below) and (d) directed that the Transactions and the Certificate of Amendment be submitted to the Company Stockholders for approval.

Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Purchase Agreements.

Conditions to the Closing

The Closing is subject to various customary mutual closing conditions, including, among others, (a) approval of the Transactions by the affirmative vote of the majority of shares of common stock, par value $0.001 per share of the Company ("Common Stock") present or represented by proxy at a special meeting of the Company Stockholders (the "Company Stockholders Meeting") and entitled to vote on such matter and the adoption of the Certificate of Amendment by the affirmative vote of the majority of shares of Common Stock outstanding and entitled to vote on such matter (collectively, "Requisite Stockholder Approvals"), (b) the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and (c) the absence of legal restraints. The obligations of the Purchasers, on the one hand, and the Company, on the other hand, to consummate the Closing are further subject to the satisfaction by the Company and the other Purchasers, respectively, of additional conditions to Closing, including, among others, the accuracy of representations and warranties subject to negotiated qualifiers, the performance of covenants in all material respects, the delivery of customary closing deliverables, with respect to the Purchasers, the reservation and approval for listing on NASDAQ of the shares of Common Stock underlying the . . .

Item 3.02. Unregistered Sales of Equity Securities.

The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein. The securities of the Company that will be issued as part of the Transactions will not initially be registered under the Securities Act in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act.

Item 3.03. Material Modification to Rights of Security Holders.

The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers.


The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein.

In connection with the Transactions contemplated under the Purchase Agreements, the Company has approved an award of $1,000,000 to Bill Livek, the Company's Chief Executive Officer and Executive Vice Chairman, in recognition of Mr. Livek's efforts to lead the Company to achieve successful completion of the Transactions, and in satisfaction of the Refinance Bonus commitment under that certain letter agreement between Mr. Livek and the Company, dated November 4, 2019 (the





                                       7

--------------------------------------------------------------------------------

"Letter Agreement"), which award is contingent upon the successful completion of the Transactions. Subject to equitable adjustment in a manner similar to that contemplated under the Purchase Agreements, this $1,000,000 Refinance Bonus shall be paid to Mr. Livek in the form of a restricted stock unit ("RSU") award issued upon the Closing (or as soon thereafter as administratively practicable) under and subject to the Company's 2018 Equity and Incentive Compensation Plan (the "Plan") (including the adjustment provisions thereunder), with the number of shares of Common Stock subject to such RSU award being determined by dividing $1,000,000 by the "Share Price," as such term is defined in the Purchase Agreement (the "Refinance RSU Award"). Mr. Livek's Refinance RSU Award will become vested on December 31, 2021, subject to Mr. Livek's continuous employment with the Company or one of its affiliates through such date; provided, that upon certain qualifying terminations of employment, Mr. Livek will become 100% vested in his Refinance RSU Award. Mr. Livek will be required to hold the net shares of Common Stock delivered to him under the Refinance RSU Award following vesting (the "Net Shares") over the three-year period following the Closing, with one-third of such Net Shares being released from such hold on each anniversary of the Closing; provided that upon a qualifying termination of employment, all holding requirements will terminate, and provided further that the holding requirements shall not apply to certain transfers for estate-planning purposes allowed under the Plan. Notwithstanding the foregoing, in the event that Mr. Livek's employment is terminated by the Company without "Cause" or by Mr. Livek for "Good Reason" (each term, as defined in the Letter Agreement) within the 90-day period preceding the Closing, Mr. Livek will remain eligible to receive the Refinance Bonus set forth in the Letter Agreement in lieu of the Refinance RSU Award.

The Company also approved the grant of certain compensatory awards, which will be subject to and effective upon the Closing, for the executive officers listed below (the "Executives"). These awards are expected to be granted in the form of RSUs under the Plan and are intended both to reward the Executives for their efforts in contributing to a successful completion of the Closing and to ensure the retention and continued focus of the Executives following the Closing. These awards have been approved for the Executives in the amounts listed below, with the number of RSUs for each Executive being determined by dividing the amounts below by the Share Price.





Name                 Title                       Amount ($)

Gregory Fink Chief Financial Officer $ 350,000 Christopher Wilson Chief Commercial Officer $ 350,000

The Executives' RSUs will vest as to one-third on each of the first three anniversaries of the Closing, subject to the applicable Executive's continued service through each vesting date, with accelerated vesting for certain qualifying terminations of employment.

Item 5.03. Amendment to Articles of Incorporation or Bylaws, Change in Fiscal


           Year.


To create the Series B Preferred Stock that will be issued as part of the Transactions under the Purchase Agreements and to have a sufficient number of authorized shares of Common Stock available into which such shares of Series B Preferred Stock may be converted, the Company will execute and file the Certificate of Designations and a Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company (the "Certificate of Amendment"). The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein.

Item 7.01. Regulation FD Disclosure.

On January 7, 2021, the Company issued a press release announcing the execution of the Purchase Agreements. The press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference.

The information in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor shall it be incorporated by reference in any filing under the U.S. Securities Act of 1933, as amended.





                                       8

--------------------------------------------------------------------------------

Cautionary Statement Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of federal and state securities laws, including, without limitation, the Company's expectations, plans and opinions regarding the Transactions; the Company's commercial agreements; future data rights; development of an industry standard or currency; retirement of debt; improvements in liquidity and financial flexibility; shareholder approval; revenue growth; and post-transaction Board composition. These statements involve risks and uncertainties that could cause actual events to differ materially from expectations, including, but not limited to, changes in the investment or commercial agreement terms, failure to receive any required government authorizations, failure to obtain the Requisite Stockholder Approvals, failure to obtain required customer, vendor or debtholder consents, delays in closing the Transactions, changes in the Company's business, external market conditions, the impact of the Covid-19 pandemic and related government mandates, and the Company's ability to achieve its expected strategic, financial and operational plans. For additional discussion of risk factors, please refer to the Company's respective Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and other filings that the Company makes from time to time with the U.S. Securities and Exchange Commission (the "SEC"), which are available on the SEC's website (www.sec.gov).

Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date such statements are made. The Company does not intend or undertake, and expressly disclaims, any duty or obligation to publicly update any forward-looking statements to reflect events, circumstances or new information after the date of this report, or to reflect the occurrence of unanticipated events.

Additional Information and Where to Find it

The Company intends to file a proxy statement (the "Proxy Statement") with the SEC in connection with the solicitation of proxies by the Company in connection with the proposed Transactions. The Company also intends to file other relevant documents with the SEC regarding the proposed Transactions. The definitive Proxy Statement will be mailed to the Company's shareholders when available. Before making any voting or investment decision with respect to the proposed Transactions, shareholders of the Company are urged to read the definitive Proxy Statement regarding the proposed Transactions (including any amendments or supplements thereto) and other relevant materials carefully and in their entirety when they become available because they will contain important information about the proposed Transactions.

The Proxy Statement, any amendments or supplements thereto and other relevant materials, and any other documents filed by the Company with the SEC, may be obtained once such documents are filed with the SEC free of charge on the SEC's website at www.sec.gov or free of charge from the Company at www.comscore.com or by directing a request to the Company's Investor Relations team at press@comscore.com or by calling 646-746-0579.

Participants in the Solicitation

The Company and its executive officers and directors and certain other members of management and employees may, under the rules of the SEC, be deemed to be "participants" in the solicitation of proxies in connection with the Transactions. Information regarding the Company's directors and executive officers is available in its Proxy Statement on Schedule 14A for its 2020 Annual Meeting of Stockholders, filed with the SEC on May 29, 2020, and in its Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on February 28, 2020. These documents may be obtained free of charge from the sources indicated above. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Proxy Statement and other relevant materials relating to the proposed Transactions to be filed with the SEC when they become available.

Item 9.01. Financial Statements and Exhibits.




(d)  Exhibits.



   Exhibit
     No.                                      Description

10.1                 Series B Convertible Preferred Stock Purchase Agreement, dated
                   as of January 7, 2021, by and between comScore, Inc. and Charter
                   Communications Holding Company, LLC

10.2                 Series B Convertible Preferred Stock Purchase Agreement, dated
                   as of January 7, 2021, by and between comScore, Inc. and Qurate
                   Retail, Inc.




                                       9

--------------------------------------------------------------------------------


   Exhibit
     No.                                    Description

10.3              Series B Convertible Preferred Stock Purchase Agreement, dated as
                of January 7, 2021, by and between comScore, Inc. and Pine
                Investor, LLC

10.4              Agreement, dated as of January 7, 2021, by and among comScore,
                Inc. and certain funds affiliated with or managed by Starboard
                Value LP

99.1              Press Release, dated January 7, 2021

101.INS         XBRL Instance Document - the instance document does not appear in
                the Interactive Data File because its XBRL tags are embedded within
                the Inline XBRL document

101.SCH         Inline XBRL Taxonomy Extension Schema Document

101.CAL         Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF         Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB         Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE         Inline XBRL Taxonomy Extension Presentation Linkbase Document

104             Cover Page Interactive Data File - the cover page iXBRL tags are
                embedded within the Inline XBRL document




                                       10

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses